StockData
VRXANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as VRXAW

Veraxa Biotech AG - Post de-SPAC

Last filing: 20-F on Jun 16, 2026
$1.00−0.11 (-9.91%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Veraxa Biotech AG - Post de-SPAC has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Veraxa Biotech AG - Post de-SPAC filed with the SEC